We studied the association between class II
human leukocyte antigen (
HLA)-DRB1*0301 presented measles virus (MV)
peptide-specific
cytokine responses and DQB1 and DPB1 alleles among 313 individuals who received two doses of
measles-
mumps-
rubella-II
vaccine. The overall median IFN-gamma secretion levels (first and third quartiles) for the 19-amino
acid MV
phosphoprotein (MV-P)- and 14-amino
acid MV
nucleoprotein (MV-N)-derived
peptides were 27.7 pg/ml (1.8, 109.4) and 1.9 pg/ml (-6.2, 13.0), respectively; median
IL-4 secretion levels were -0.6 pg/ml (-7.1, 6.2) and 2.4 pg/ml (-3.2, 9.3), respectively. Primary statistical analyses were adjusted for previously identified DRB1 associations. A marginally significant increase in the frequency of the DQB1*0604 (p=0.02) allele was found among subjects who demonstrated detectable
IL-4 levels to the MV-P
peptide. Further, DPB1*0201 (p=0.02) and DPB1*1301 (p=0.09) alleles provided suggestive evidence of an association with MV-P-induced
IL-4 secretion. Examination of IFN-gamma responses to MV-P and MV-N indicated that none of the individual alleles of the DQB1 and DPB1 loci were associated with
peptide-induced T cell response. An increase in the frequency of DPB1*0501 (p=0.01) was found among subjects who failed to produce MV-N
peptide-specific
IL-4 responses. These data further confirm that
HLA-DRB1 alleles are the major restriction molecules for MV-P and MV-N measles virus antigen presentation to T cells. We speculate that MV-P and MV-N
peptides derived from DRB1*0301 could potentially be recognized in association with different HLA molecules, including DQB1 and DPB1; however, statistical adjustments for the effect of
HLA-DR locus could potentially alter these genetic relationships. This concept provides important information supporting the use of promiscuous
peptides in a
peptide-based
vaccine approach.